A Small-Molecule Modulator of Metal Homeostasis in Gram-Positive Pathogens

Author:

Juttukonda Lillian J.12,Beavers William N.12,Unsihuay Daisy12,Kim Kwangho3,Pishchany Gleb4,Horning Kyle J.5,Weiss Andy12,Al-Tameemi Hassan6,Boyd Jeffrey M.6ORCID,Sulikowski Gary A.137,Bowman Aaron B.5,Skaar Eric P.12

Affiliation:

1. Vanderbilt Institute for Infection, Immunology and Inflammation, Vanderbilt University Medical Center, Nashville, Tennessee, USA

2. Department of Pathology, Microbiology, and Immunology, Vanderbilt University Medical Center, Nashville, Tennessee, USA

3. Chemical Synthesis Core, Vanderbilt University, Nashville, Tennessee, USA

4. Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, Massachusetts, USA

5. Vanderbilt Brain Institute, Department of Pediatrics, Vanderbilt University School of Medicine, Nashville, Tennessee, USA

6. Department of Biochemistry and Microbiology, Rutgers, the State University of New Jersey, New Brunswick, New Jersey, USA

7. Department of Chemistry, Vanderbilt University, Nashville, Tennessee, USA

Abstract

Staphylococcus aureus is a leading agent of antibiotic-resistant bacterial infections in the world. S. aureus tightly controls metal homeostasis during infection, and disruption of metal uptake systems impairs staphylococcal virulence. We identified small molecules that interfere with metal handling in S. aureus to develop chemical probes to investigate metallobiology in this organism. Compound VU0026921 was identified as a small molecule that kills S. aureus both aerobically and anaerobically. The activity of VU0026921 is modulated by metal supplementation, is enhanced by genetic inactivation of Mn homeostasis genes, and correlates with increased cellular reactive oxygen species. Treatment with VU0026921 causes accumulation of multiple metals within S. aureus cells and concomitant upregulation of genes involved in metal detoxification. This work defines a small-molecule probe for further defining the role of metal toxicity in S. aureus and validates future antibiotic development targeting metal toxicity pathways.

Funder

HHS | NIH | National Institute of Allergy and Infectious Diseases

National Science Foundation

HHS | NIH | National Institute of General Medical Sciences

American Heart Association

U.S. Department of Agriculture

HHS | NIH | National Institute of Environmental Health Sciences

DOD | Defense Advanced Research Projects Agency

Publisher

American Society for Microbiology

Subject

Virology,Microbiology

Reference77 articles.

1. A Brief History of the Antibiotic Era: Lessons Learned and Challenges for the Future

2. Past, Present, and Future of Antibacterial Economics: Increasing Bacterial Resistance, Limited Antibiotic Pipeline, and Societal Implications

3. Silver LL, Bush K. 2016. Antibiotics and antibiotic resistance. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.

4. CDC. 2019. Antibiotic resistance threats in the United States. CDC Atlanta GA. https://www.cdc.gov/DrugResistance/Biggest-Threats.html.

5. WHO. 2017. Global priority list of antibiotic-resistant bacteria to guide research discovery and development of new antibiotics. WHO Geneva Switzerland. https://www.who.int/medicines/publications/WHO-PPL-Short_Summary_25Feb-ET_NM_WHO.pdf.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3